DaVita Wins Preliminary Approval for Ransomware Class Action Settlement
DVA sits 81% above its 52-week low of $101 on light trading volume (0.1× avg).
Summary
A federal court granted preliminary approval to a class action settlement stemming from the April 2025 ransomware attack by Interlock, which exposed personal and health data of roughly 1.2 million individuals. The settlement class covers 2.3 million current and former patients, consolidating 10 lawsuits. DaVita denies liability but agreed to mediate, and the court will now notify class members before a final fairness hearing. This is a material legal development for a company with an $11.7 billion market cap, though the financial terms of the settlement are not disclosed. The next step is the final approval hearing, which will determine the adequacy of relief and attorney fees.
At the time of this announcement, DVA was trading at $182.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.7B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Benzinga.